Literature DB >> 28439450

Peritoneal carcinomatosis of colorectal cancer is characterized by structural and functional reorganization of the tumor microenvironment inducing senescence and proliferation arrest in cancer cells.

Caroline Theresa Seebauer1, Stefan Brunner1, Gabriel Glockzin1, Pompiliu Piso1, Petra Ruemmele2, Hans-Juergen Schlitt1, Edward Kenneth Geissler1, Stefan Fichtner-Feigl1,3, Rebecca Kesselring1,3.   

Abstract

Background : Peritoneal carcinomatosis (PC) is a terminal evolution from primary colorectal cancer (pCRC) associated with poor patient survival. Impact of the immune cell infiltrate on PC pathogenesis is unknown. Therefore, we characterized the immunological tumor microenvironment regarding proliferation, senescence and neovascularization. Methods : Formalin-fixed and paraffin-embedded (FFPE) tissue of PC and pCRC was examined by immunohistochemistry. Cells infiltrating resected tissue were isolated and analyzed by flow cytometry. PCR arrays detected the expression of genes relevant for helper T (TH) cell responses, like TH1, TH2 and TH17 response. Results : PC tumor cells demonstrate significantly lower proliferation rates than pCRC, but show significantly more senescence. PC is surrounded by significantly increased numbers of cytotoxic active Natural Killer (NK) cells, follicular helper T cells (TFH) and B cells, whereas pCRC shows more CD4+ TH cells, CD8+ cytotoxic T (TC) cells, eosinophilic granulocytes, TH17 and regulatory T (Treg) cells. PC is characterized by significantly increased interferon-γ (IFNγ), an upregulation of tumor necrosis factor (TNF) and the NK cell-regulating cytokine interleukin-15 (IL-15). An upregulation of angiogenesis-related genes, like vascular endothelial growth factor-A (VEGF-A), leads to severe neovascularization in PC. Correlations of PC results reveal that elevated numbers of interleukin-17 (IL-17) positive cells are associated with high cancer cell proliferation, whereas high numbers of IFNγ positive cells correlate with more tumor cells in senescence. Conclusion : The cellular immune reaction is modified during metastasis, inducing senescence in PC tumor cells. Immune surveillance in PC is facilitated by NK cells and high levels of IFNγ and TNF. Counteracting this effect, TFH and B cells combined with VEGF-A enhancement promote neovascularization in PC (Illustration 1). During metastasis from primary CRC to PC the immune cell infiltrate changes, accompanied by the induction of senescence in PC cancer cells (marked red): In pCRC, the antitumor immune response is facilitated by CD4+TH cells, CD8+TC cells and PRG2+ eosinophilic granulocytes. The premetastatic niche development is promoted by Treg cells and TH17 cells producing systemic factors like VEGF-A, TGF-β and TNF. Along with TFH and B cells, as with a pro-tumor immune response, they support metastatic formation and lead to severe neovascularization in PC. This is counterbalanced by the IL-15-induced activation and proliferation of NK cells. The secreted cytokines IFNγ and TNF mediate immunosurveillance.

Entities:  

Keywords:  Peritoneal carcinomatosis; TH1; TH17; proliferation; senescence; tumor milieu

Year:  2016        PMID: 28439450      PMCID: PMC5391678          DOI: 10.1080/2162402X.2016.1242543

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  53 in total

Review 1.  Assessing cell and organ senescence biomarkers.

Authors:  Bruno Bernardes de Jesus; Maria A Blasco
Journal:  Circ Res       Date:  2012-06-22       Impact factor: 17.367

Review 2.  T(H)17 cells in tumour immunity and immunotherapy.

Authors:  Weiping Zou; Nicholas P Restifo
Journal:  Nat Rev Immunol       Date:  2010-04       Impact factor: 53.106

Review 3.  Anti-EGFR and anti-VEGF agents: important targeted therapies of colorectal liver metastases.

Authors:  Qing-Yang Feng; Ye Wei; Jing-Wen Chen; Wen-Ju Chang; Le-Chi Ye; De-Xiang Zhu; Jian-Min Xu
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 4.  The good, the bad and the ugly - TFH cells in human health and disease.

Authors:  Stuart G Tangye; Cindy S Ma; Robert Brink; Elissa K Deenick
Journal:  Nat Rev Immunol       Date:  2013-05-17       Impact factor: 53.106

5.  Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice.

Authors:  Dominik Jauch; Maria Martin; Gabriela Schiechl; Rebecca Kesselring; Hans Jürgen Schlitt; Edward K Geissler; Stefan Fichtner-Feigl
Journal:  Gut       Date:  2011-09-23       Impact factor: 23.059

6.  RORγt(+) hematopoietic cells are necessary for tumor cell proliferation during colitis-associated tumorigenesis in mice.

Authors:  Maria Martin; Rebecca K Kesselring; Balam Saidou; Stefan M Brunner; Gabriela Schiechl; Verena F Mouris; Anja K Wege; Petra Rümmele; Hans J Schlitt; Edward K Geissler; Stefan Fichtner-Feigl
Journal:  Eur J Immunol       Date:  2015-05-15       Impact factor: 5.532

7.  H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance.

Authors:  Amy V Paschall; Dafeng Yang; Chunwan Lu; Jeong-Hyeon Choi; Xia Li; Feiyan Liu; Mario Figueroa; Nicholas H Oberlies; Cedric Pearce; Wendy B Bollag; Asha Nayak-Kapoor; Kebin Liu
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

Review 8.  Roles of TGFbeta in metastasis.

Authors:  David Padua; Joan Massagué
Journal:  Cell Res       Date:  2009-01       Impact factor: 25.617

Review 9.  The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis.

Authors:  Sandra S McAllister; Robert A Weinberg
Journal:  Nat Cell Biol       Date:  2014-08       Impact factor: 28.824

10.  Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.

Authors:  Boryana K Popivanova; Kazuya Kitamura; Yu Wu; Toshikazu Kondo; Takashi Kagaya; Shiuchi Kaneko; Masanobu Oshima; Chifumi Fujii; Naofumi Mukaida
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

View more
  11 in total

Review 1.  Advances in the management of peritoneal malignancies.

Authors:  Vahan Kepenekian; Aditi Bhatt; Julien Péron; Mohammad Alyami; Nazim Benzerdjeb; Naoual Bakrin; Claire Falandry; Guillaume Passot; Pascal Rousset; Olivier Glehen
Journal:  Nat Rev Clin Oncol       Date:  2022-09-07       Impact factor: 65.011

2.  Senescent Tumor Cells in the Peritoneal Carcinomatosis Drive Immunosenescence in the Tumor Microenvironment.

Authors:  Heidi Braumüller; Bernhard Mauerer; Christopher Berlin; Dorothea Plundrich; Patrick Marbach; Pierre Cauchy; Claudia Laessle; Esther Biesel; Philipp Anton Holzner; Rebecca Kesselring
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

3.  The Construction and Analysis of ceRNA Network and Patterns of Immune Infiltration in Colon Adenocarcinoma Metastasis.

Authors:  Zhengyan Chang; Runzhi Huang; Wanting Fu; Jiehan Li; Guo Ji; Jinglei Huang; Weijun Shi; Huabin Yin; Weifeng Wang; Tong Meng; Zongqiang Huang; Qing Wei; Huanlong Qin
Journal:  Front Cell Dev Biol       Date:  2020-08-04

4.  Perioperative changes in lymphocyte subpopulations in patients undergoing surgery for colorectal cancer.

Authors:  Mateusz Rubinkiewicz; Izabela Siemińska; Piotr Małczak; Piotr Major; Jarosław Baran; Andrzej Budzyński; Michał Pędziwiatr
Journal:  Acta Clin Croat       Date:  2019-06       Impact factor: 0.780

Review 5.  Peritoneal Metastasis: Current Status and Treatment Options.

Authors:  Lilian Roth; Linda Russo; Sima Ulugoel; Rafael Freire Dos Santos; Eva Breuer; Anurag Gupta; Kuno Lehmann
Journal:  Cancers (Basel)       Date:  2021-12-23       Impact factor: 6.639

6.  Serum Inflammatory Biomarkers Contribute to the Prognosis Prediction in High-Grade Glioma.

Authors:  Xiao-Yong Chen; Ding-Long Pan; Jia-Heng Xu; Yue Chen; Wei-Feng Xu; Jin-Yuan Chen; Zan-Yi Wu; Yuan-Xiang Lin; Hong-Hai You; Chen-Yu Ding; De-Zhi Kang
Journal:  Front Oncol       Date:  2022-01-27       Impact factor: 6.244

Review 7.  Fundamental and Essential Knowledge for Pathologists Engaged in the Research and Practice of Immune Checkpoint Inhibitor-Based Cancer Immunotherapy.

Authors:  Terufumi Kubo; Tomoyo Shinkawa; Yasuhiro Kikuchi; Kenji Murata; Takayuki Kanaseki; Tomohide Tsukahara; Yoshihiko Hirohashi; Toshihiko Torigoe
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 6.244

8.  Abundant intratumoral fibrosis prevents lymphocyte infiltration into peritoneal metastases of colorectal cancer.

Authors:  En Wang; Masatsune Shibutani; Hisashi Nagahara; Tatsunari Fukuoka; Yasuhito Iseki; Yuki Okazaki; Shinichiro Kashiwagi; Hiroaki Tanaka; Kiyoshi Maeda; Kosei Hirakawa; Masaichi Ohira
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

9.  Establishment and Validation of a Prognostic Immune Signature in Neuroblastoma.

Authors:  Yunhu Yu; Yu Zeng; Xiangping Xia; Jian-Guo Zhou; Fang Cao
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

Review 10.  Cytokine-Induced Senescence in the Tumor Microenvironment and Its Effects on Anti-Tumor Immune Responses.

Authors:  Maximilian Rentschler; Heidi Braumüller; Priscilla S Briquez; Thomas Wieder
Journal:  Cancers (Basel)       Date:  2022-03-08       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.